OracleBio will be attending the 34th Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2019), which takes place from the 6th to 10th of November 2019 at the Gaylord National Hotel & Convention Center in National Harbor, MD.
OracleBio will be exhibiting at Booth 227 throughout the meeting.
OracleBio offers a range of digital pathology services to support pre-clinical and clinical oncology R&D. Using immunohistochemistry and immunoflourescence techniques, we are able to produce a variety of quantifiable results valuable to oncology research, such as immune cell number, immune cell co-localisation and spatial distribution within the tumor microenvironment. Click here to find out more information about how our services can support your oncology research.
The 34th Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2019) will cover the latest strategies in basic and applied cancer immunotherapy that deliver improved outcomes for patients. The annual meeting will comprise expert-led oral and poster presentations on cutting-edge research and provide ample opportunities for networking and discussions. To find out more about SITC 2019, please click here.
John Waller, Chief Operations Officer, along with Keith Bowers, Senior Business Development Manager, and Mark Anderson, Senior Project Manager, will be in attendance throughout the meeting. If you would like to learn more about OracleBio’s services or arrange a meeting please contact us.
To keep up to date with all OracleBio news and events, follow us on LinkedIn by clicking the button below: